Daan Gene Co., Ltd. (SHE:002030)

China flag China · Delayed Price · Currency is CNY
6.02
+0.01 (0.17%)
May 23, 2025, 2:45 PM CST
-12.24%
Market Cap 8.45B
Revenue (ttm) 823.85M
Net Income (ttm) -508.95M
Shares Out 1.40B
EPS (ttm) -0.37
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date Jun 14, 2024
Volume 17,363,579
Average Volume 15,820,675
Open 5.99
Previous Close 6.01
Day's Range 5.99 - 6.15
52-Week Range 4.71 - 7.32
Beta 0.83
RSI 57.97
Earnings Date Apr 30, 2025

About Daan Gene

Daan Gene Co., Ltd., together with its subsidiaries, researches and develops, manufactures, and sells clinical test reagents, instruments, and supporting consumables in China. It operates through Biological Products and Related Business and Financial Business segments. The company offers reagents for hepatitis virus, sexually transmitted infections, blood screening, digestive pathogens, coronavirus disease (COVID-19), pharmacogenomics, viral transport medium, human papillomavirus, human immunodeficiency virus, respiratory infections, public hea... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1988
Employees 1,730
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002030
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.